Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

XL-647/sorafenib combination shows promise in preclinical models of HCC

April 26, 2010

Boehringer Ingelheim identifies new B-raf inhibitors

April 26, 2010

Delcath reports phase III data on Delcath PHP System-delivered melphalan

April 23, 2010

Genmab begins new next-generation antibody program HuMax-cMet

April 23, 2010

Nerviano Medical Sciences discovers new B-raf inhibitors for cancer therapy

April 23, 2010

AstraZeneca discloses novel Janus kinase inhibitors

April 23, 2010

Merck Serono claims novel PI3K inhibitors

April 23, 2010

NeoPharm starts enrollment in phase II LE-DT trial in pancreatic cancer

April 22, 2010

EMA's COMP notifies CytRX of positive opinion on bafetinib in CML

April 22, 2010

Novel photosensitizer porphyrins discovered at CeramOptec

April 22, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...